vs
CANTALOUPE, INC.（CTLP）与IRONWOOD PHARMACEUTICALS INC（IRWD）财务数据对比。点击上方公司名可切换其他公司
CANTALOUPE, INC.的季度营收约是IRONWOOD PHARMACEUTICALS INC的1.6倍（$78.7M vs $47.7M），CANTALOUPE, INC.净利率更高（-0.1% vs -4.8%，领先4.7%），CANTALOUPE, INC.同比增速更快（6.8% vs -47.3%），IRONWOOD PHARMACEUTICALS INC自由现金流更多（$74.6M vs $-614.0K），过去两年CANTALOUPE, INC.的营收复合增速更高（7.7% vs -20.2%）
坎塔卢波（原美国技术公司）是一家美国科技企业，核心业务为ePort无现金支付受理技术，依托持专利的PCI合规ePort Connect服务开展运营。该服务可通过无线方式为消费者提供信用卡、借记卡以及Apple Pay、Google Pay等NFC钱包支付选项，同时为运营商提供遥测与机器间通信服务，ePort技术主要应用于...
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
CTLP vs IRWD — 直观对比
营收规模更大
CTLP
是对方的1.6倍
$47.7M
营收增速更快
CTLP
高出54.1%
-47.3%
净利率更高
CTLP
高出4.7%
-4.8%
自由现金流更多
IRWD
多$75.2M
$-614.0K
两年增速更快
CTLP
近两年复合增速
-20.2%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $78.7M | $47.7M |
| 净利润 | $-70.0K | $-2.3M |
| 毛利率 | — | — |
| 营业利润率 | 2.0% | 14.3% |
| 净利率 | -0.1% | -4.8% |
| 营收同比 | 6.8% | -47.3% |
| 净利润同比 | -101.4% | -200.9% |
| 每股收益（稀释后） | $0.00 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTLPIRWD
| Q4 25 | $78.7M | $47.7M | ||
| Q3 25 | $80.9M | $122.1M | ||
| Q2 25 | $82.6M | $85.2M | ||
| Q1 25 | $75.4M | $41.1M | ||
| Q4 24 | $73.7M | $90.5M | ||
| Q3 24 | $70.8M | $91.6M | ||
| Q2 24 | $72.7M | $94.4M | ||
| Q1 24 | $67.9M | $74.9M |
净利润CTLPIRWD
| Q4 25 | $-70.0K | $-2.3M | ||
| Q3 25 | $-919.0K | $40.1M | ||
| Q2 25 | $6.8M | $23.6M | ||
| Q1 25 | $49.2M | $-37.4M | ||
| Q4 24 | $5.0M | $2.3M | ||
| Q3 24 | $3.6M | $3.6M | ||
| Q2 24 | $2.2M | $-860.0K | ||
| Q1 24 | $4.7M | $-4.2M |
毛利率CTLPIRWD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 39.6% | — |
营业利润率CTLPIRWD
| Q4 25 | 2.0% | 14.3% | ||
| Q3 25 | 2.0% | 61.8% | ||
| Q2 25 | 6.3% | 53.2% | ||
| Q1 25 | 9.1% | -70.7% | ||
| Q4 24 | 8.4% | 34.8% | ||
| Q3 24 | 5.8% | 28.0% | ||
| Q2 24 | 4.9% | 26.5% | ||
| Q1 24 | 6.3% | 14.7% |
净利率CTLPIRWD
| Q4 25 | -0.1% | -4.8% | ||
| Q3 25 | -1.1% | 32.8% | ||
| Q2 25 | 8.3% | 27.7% | ||
| Q1 25 | 65.2% | -90.9% | ||
| Q4 24 | 6.7% | 2.5% | ||
| Q3 24 | 5.0% | 4.0% | ||
| Q2 24 | 3.0% | -0.9% | ||
| Q1 24 | 6.9% | -5.6% |
每股收益（稀释后）CTLPIRWD
| Q4 25 | $0.00 | $0.01 | ||
| Q3 25 | $-0.02 | $0.23 | ||
| Q2 25 | $0.10 | $0.14 | ||
| Q1 25 | $0.65 | $-0.23 | ||
| Q4 24 | $0.07 | $0.03 | ||
| Q3 24 | $0.04 | $0.02 | ||
| Q2 24 | $0.03 | $-0.01 | ||
| Q1 24 | $0.06 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $53.0M | $215.5M |
| 总债务越低越好 | $37.7M | — |
| 股东权益账面价值 | $252.5M | $-261.8M |
| 总资产 | $381.9M | $396.9M |
| 负债/权益比越低杠杆越低 | 0.15× | — |
8季度趋势，按日历期对齐
现金及短期投资CTLPIRWD
| Q4 25 | $53.0M | $215.5M | ||
| Q3 25 | $55.0M | $140.4M | ||
| Q2 25 | $51.1M | $92.9M | ||
| Q1 25 | $46.3M | $108.5M | ||
| Q4 24 | $27.7M | $88.6M | ||
| Q3 24 | $33.1M | $88.2M | ||
| Q2 24 | $58.9M | $105.5M | ||
| Q1 24 | $50.2M | $121.5M |
总债务CTLPIRWD
| Q4 25 | $37.7M | — | ||
| Q3 25 | $38.3M | $199.5M | ||
| Q2 25 | $38.7M | $199.3M | ||
| Q1 25 | $39.2M | $199.2M | ||
| Q4 24 | $37.0M | $199.0M | ||
| Q3 24 | $37.3M | $198.8M | ||
| Q2 24 | $37.5M | $198.6M | ||
| Q1 24 | $38.1M | $398.3M |
股东权益CTLPIRWD
| Q4 25 | $252.5M | $-261.8M | ||
| Q3 25 | $251.8M | $-264.2M | ||
| Q2 25 | $251.0M | $-308.2M | ||
| Q1 25 | $240.7M | $-334.1M | ||
| Q4 24 | $190.1M | $-301.3M | ||
| Q3 24 | $186.2M | $-311.3M | ||
| Q2 24 | $181.7M | $-321.7M | ||
| Q1 24 | $178.8M | $-330.5M |
总资产CTLPIRWD
| Q4 25 | $381.9M | $396.9M | ||
| Q3 25 | $389.5M | $396.1M | ||
| Q2 25 | $381.9M | $342.9M | ||
| Q1 25 | $370.5M | $327.2M | ||
| Q4 24 | $303.0M | $350.9M | ||
| Q3 24 | $312.1M | $389.5M | ||
| Q2 24 | $335.6M | $395.6M | ||
| Q1 24 | $319.9M | $438.8M |
负债/权益比CTLPIRWD
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.19× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.21× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.1M | $74.6M |
| 自由现金流经营现金流 - 资本支出 | $-614.0K | $74.6M |
| 自由现金流率自由现金流/营收 | -0.8% | 156.3% |
| 资本支出强度资本支出/营收 | 4.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $25.8M | $127.0M |
8季度趋势，按日历期对齐
经营现金流CTLPIRWD
| Q4 25 | $3.1M | $74.6M | ||
| Q3 25 | $7.0M | $47.6M | ||
| Q2 25 | $9.4M | $-15.1M | ||
| Q1 25 | $22.4M | $20.0M | ||
| Q4 24 | $522.0K | $15.2M | ||
| Q3 24 | $-12.0M | $9.9M | ||
| Q2 24 | $14.3M | $33.5M | ||
| Q1 24 | $14.7M | $45.0M |
自由现金流CTLPIRWD
| Q4 25 | $-614.0K | $74.6M | ||
| Q3 25 | $3.5M | $47.6M | ||
| Q2 25 | $4.3M | $-15.1M | ||
| Q1 25 | $18.6M | $19.9M | ||
| Q4 24 | $-3.8M | — | ||
| Q3 24 | $-15.8M | $9.9M | ||
| Q2 24 | $8.5M | $33.4M | ||
| Q1 24 | $11.4M | $44.9M |
自由现金流率CTLPIRWD
| Q4 25 | -0.8% | 156.3% | ||
| Q3 25 | 4.4% | 39.0% | ||
| Q2 25 | 5.3% | -17.7% | ||
| Q1 25 | 24.6% | 48.4% | ||
| Q4 24 | -5.1% | — | ||
| Q3 24 | -22.3% | 10.8% | ||
| Q2 24 | 11.7% | 35.4% | ||
| Q1 24 | 16.9% | 60.0% |
资本支出强度CTLPIRWD
| Q4 25 | 4.8% | 0.0% | ||
| Q3 25 | 4.2% | 0.0% | ||
| Q2 25 | 6.2% | 0.0% | ||
| Q1 25 | 5.1% | 0.1% | ||
| Q4 24 | 5.8% | 0.0% | ||
| Q3 24 | 5.4% | 0.0% | ||
| Q2 24 | 7.9% | 0.1% | ||
| Q1 24 | 4.8% | 0.1% |
现金转化率CTLPIRWD
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | 1.38× | -0.64× | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.10× | 6.74× | ||
| Q3 24 | -3.36× | 2.71× | ||
| Q2 24 | 6.47× | — | ||
| Q1 24 | 3.16× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTLP
| Transaction Processing | $47.9M | 61% |
| Subscription Revenue | $21.8M | 28% |
| Products | $9.0M | 11% |
IRWD
暂无分部数据
